Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer

Clinical trial NCT01605916 · COMPLETED

Trial details

NCT number: NCT01605916
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms,Metastatic Cancer,Non-Small Cell Lung Cancer Advanced Solid Malignancies

Start date: 2012-06-01
Primary completion: 2015-04-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.